# Does gradual weaning improve outcomes after successful Pavlik harness treatment in developmental hip dysplasia? A retrospective comparative study

**Authors:** Soner Kocak, Sabri Kerem Diril, Mustafa Caliskan, Gurkan Caliskan, Esref Terzi, Ali Ozyalcin, Sumeyra Dogan, Mehmet Akif Sahin, Adem Sahin, Abdulhamit Misir, Cemil Erturk

PMC · DOI: 10.1007/s00402-026-06239-x · Archives of Orthopaedic and Trauma Surgery · 2026-02-18

## TL;DR

This study compares stopping the Pavlik harness immediately versus gradually in infants with hip dysplasia, finding similar outcomes but potential benefits and risks with gradual weaning.

## Contribution

The study provides new comparative evidence on discontinuation strategies after Pavlik harness treatment for hip dysplasia.

## Key findings

- Immediate discontinuation and gradual weaning had similar recurrence and AVN rates.
- Gradual weaning showed a non-significant trend toward better acetabular development.
- Prolonged abduction in gradual weaning may slightly increase AVN risk.

## Abstract

The Pavlik harness is the standard first-line treatment for developmental dysplasia of the hip (DDH) in infants younger than six months. However, the optimal strategy for discontinuation after successful hip reduction remains debated. This study aimed to compare clinical and radiological outcomes between immediate discontinuation and gradual weaning using the Frejka pillow following successful Pavlik harness treatment.

We retrospectively analyzed data from 144 infants (166 hips) with DDH treated with the Pavlik harness between 2012 and 2023. Patients were categorized into two groups: Group A underwent immediate cessation, while Group B was gradually weaned using a Frejka pillow. Radiological follow-up included acetabular index (AI), lateral center-edge angle (LCEA), and assessment of AVN based on the Kalamchi-MacEwen classification, up to five years of age.

The two groups were demographically similar. There were no statistically significant differences in recurrence rates (Group A: 9%, Group B: 5%; p = 0.53) or AVN incidence (Group A: 6.25%, Group B: 10%; p = 0.55). Group B showed a non-significant trend toward higher LCEA values at five years (p = 0.08), potentially indicating better acetabular development. However, the slightly increased AVN rate in this group raises concerns regarding prolonged abduction.

Both immediate discontinuation and gradual weaning protocols yield comparable outcomes in terms of recurrence and AVN. While gradual weaning may offer marginal benefit in acetabular development, the potential vascular risks warrant further investigation. Larger prospective studies are needed to establish standardized discontinuation guidelines in DDH management.

III, retrospective comparative study.

## Linked entities

- **Diseases:** developmental dysplasia of the hip (MONDO:0000158), avascular necrosis (MONDO:0018373)

## Full-text entities

- **Diseases:** paralysis (MESH:D010243), prematurity (MESH:C536271), overweight (MESH:D050177), gait abnormalities (MESH:D020233), chronic hip pain (MESH:D059350), joint contractures (MESH:D003286), osteoarthritis (MESH:D010003), acetabular dysplasia (OMIM:142700), neuromuscular disorders (MESH:D009468), dysplasia (MESH:D015792), Pavlik disease (MESH:D004194), hip dislocation (MESH:D006617), femoral nerve palsy (MESH:D020428), DDH (MESH:D000082602), limb length discrepancy (MESH:D007870), AVN (MESH:D010020)
- **Chemicals:** Pavlik (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12917048/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12917048/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC12917048/full.md

---
Source: https://tomesphere.com/paper/PMC12917048